Drug intelligence / Profile preview

LSI-202

Development stage
Preclinical
Lead developer
LipoSeuticals
Modality
Small Molecules
Administration
Intravenous
01

Overview

LSI-202 is an intravenous lipid-based reformulation of the microtubule-stabilizing agent paclitaxel, developed by LipoSeuticals for the treatment of various cancers. Paclitaxel, a member of the taxane family, exerts its antineoplastic effect by binding to the beta-subunit of tubulin, which promotes the assembly of microtubules and inhibits their disassembly. This stabilization interferes with the dynamic instability of microtubules necessary for mitotic spindle formation, leading to cell cycle arrest in the G2/M phase and subsequent programmed cell death (apoptosis). LSI-202 utilizes a proprietary delivery system designed to enhance the solubility and pharmacological profile of paclitaxel, potentially reducing the side effects associated with conventional formulations that require surfactants like Cremophor EL.

Other names
paclitaxel
02

Targets

TUBB (Tubulin (alpha and beta subunits))

Beyond the preview

Go deeper on LSI-202.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LSI-202.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call